<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03976531</url>
  </required_header>
  <id_info>
    <org_study_id>IB2017-GCODE</org_study_id>
    <nct_id>NCT03976531</nct_id>
  </id_info>
  <brief_title>Geriatric Core Dataset (G-CODE) for Clinical Research in Elderly Cancer Patients</brief_title>
  <acronym>G-CODE</acronym>
  <official_title>Multidisciplinary Development of the Geriatric Core Dataset for Clinical Research in Older Patients With Cancer: A French Initiative With International Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Bergonié</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Plate-forme PACAN (Elderly and Cancer Platform)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Georges Pompidou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Ambroise Paré Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Curie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Leon Berard</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Claudius Regaud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saint-Louis Hospital, Paris, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Avicenne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>City of Hope Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Bergonié</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older adults with cancer remain underrepresented in cancer clinical trials that establish new&#xD;
      standards of care. Geriatric assessment (GA) is defined by geriatricians as a&#xD;
      multidimensional interdisciplinary assessment of the general health stat us of the older&#xD;
      patient, reviewing the medical, psychosocial, functional and environmental domains. For each&#xD;
      domain, several tools are available, but consensus is lacking on which tool to use and the&#xD;
      optimal cut-offs or threshold scores. The literature supports the prognostic value of the GA&#xD;
      and its utility in weighing the benefits and risks of cancer treatments in older adults.&#xD;
      However, GA has not been implemented in routine oncology practice or in cancer clinical&#xD;
      trials.&#xD;
&#xD;
      The objective of this project is to develop a set of geriatric data, the Geriatric Core&#xD;
      Dataset (G-CODE), to be collected in cancer trials of older patients. The methods rely on a&#xD;
      consensus process involving international experts in the field of oncology and geriatrics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although cancer is prevalent in the older segment of the population, older adults with cancer&#xD;
      remain underrepresented in cancer clinical trials that establish new standards of care. As a&#xD;
      result, robust data on the benefit/risk balance are lacking for many treatment strategies in&#xD;
      these patients.&#xD;
&#xD;
      Ageing is a heterogeneous process that stresses the clinical need to identify comorbid&#xD;
      conditions and ageing-related physiologic changes, both well-known factors increasing the&#xD;
      risk of treatment side-effects and poor outcomes.&#xD;
&#xD;
      Geriatric assessment (GA) is defined by geriatricians as a multidimensional interdisciplinary&#xD;
      assessment of the general health stat us of the older patient, reviewing the medical,&#xD;
      psychosocial, functional and environmental domains. For each domain, several tools are&#xD;
      available, but consensus is lacking on which tool to use and the optimal cut-offs or&#xD;
      threshold scores. The literature supports the prognostic value of the GA and its utility in&#xD;
      weighing the benefits and risks of cancer treatments in older adults. However, GA has not&#xD;
      been implemented in routine oncology practice or in cancer clinical trials.&#xD;
&#xD;
      In 2011, after a workshop on clinical trial methodology in older adults with cancer, the&#xD;
      Elderly Task Force of the European Organization for Research and Treatment of Cancer (EORTC)&#xD;
      recommended the use of a standardised minimum data set (minDS) for assessing the global&#xD;
      health and functional status of older populations. This minDS consisted of the G8 screening&#xD;
      tool, the Instrumental Activities of Daily Living Following a consensus approach, a panel of&#xD;
      14 geriatricians from oncology clinics identified seven domains of importance in geriatric&#xD;
      assessment. Based on the international recommendations, geriatricians selected the mostly&#xD;
      commonly used tools/items for geriatric assessment by domain. The Geriatric Core Dataset&#xD;
      (G-CODE) was progressively developed according to RAND appropriateness ratings and feedback&#xD;
      during three successive Delphi rounds. The face validity of the G-CODE was assessed with two&#xD;
      large panels of health professionals (55 national and 42 international experts) involved both&#xD;
      in clinical practice and cancer trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1, 2015</start_date>
  <completion_date type="Actual">January 1, 2017</completion_date>
  <primary_completion_date type="Actual">January 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Question &quot;Do You Live Alone ?&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Question &quot;do You Have a Person or Caregiver Able to Provide Care and Support&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Tool &quot;ADL (Activities of Daily Living)&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Tool &quot;4-IADL (Instrumental Activities of Daily Living)&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Test &quot;Timed Up and Go&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Items &quot;Weight Loss During the Past 6 Months and Body Mass Index (BMI)&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Item &quot;One Cognitive Scale (Mini-Cog)&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Experts Who Considered That the Item &quot;Char Lson Comorbidity Index&quot; Should be Retained in the G-CODE</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">42</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Elderly cancer patients included in randomized controlled trials</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The panel of experts (cancer specialists, clinical research associates, nurses) was in&#xD;
        charge of assessing the the relevance and approppriateness of the selected tools to include&#xD;
        in the Geriatric Core Data Set (G-Code).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  cancer specialists (medical oncologists, surgeons, radiation oncologists,&#xD;
             geriatricians, disease-oriented oncologists, clinical oncologists)&#xD;
&#xD;
          -  clinical research associates&#xD;
&#xD;
          -  nurses.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Simone Mathoulin-Pélissier, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Bergonié</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Bergonié, Comprehensive Cancer Center</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Paillaud E, Soubeyran P, Caillet P, Cudennec T, Brain E, Terret C, Etchepare F, Mourey L, Aparicio T, Pamoukdjian F, Audisio RA, Rostoft S, Hurria A, Bellera C, Mathoulin-Pélissier S; G-CODE collaborators. Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. Eur J Cancer. 2018 Nov;103:61-68. doi: 10.1016/j.ejca.2018.07.137. Epub 2018 Sep 11.</citation>
    <PMID>30212804</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>May 23, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <results_first_submitted>November 25, 2020</results_first_submitted>
  <results_first_submitted_qc>December 30, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 20, 2021</results_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>elderly</keyword>
  <keyword>randomized trial</keyword>
  <keyword>consensus</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>National Panel of Experts</title>
          <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>National Panel of Experts</title>
          <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&gt;= 18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Question &quot;Do You Live Alone ?&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Question &quot;Do You Live Alone ?&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Question &quot;do You Have a Person or Caregiver Able to Provide Care and Support&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Question &quot;do You Have a Person or Caregiver Able to Provide Care and Support&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Tool &quot;ADL (Activities of Daily Living)&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Tool &quot;ADL (Activities of Daily Living)&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Tool &quot;4-IADL (Instrumental Activities of Daily Living)&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Tool &quot;4-IADL (Instrumental Activities of Daily Living)&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Test &quot;Timed Up and Go&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Test &quot;Timed Up and Go&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Items &quot;Weight Loss During the Past 6 Months and Body Mass Index (BMI)&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Items &quot;Weight Loss During the Past 6 Months and Body Mass Index (BMI)&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Item &quot;One Cognitive Scale (Mini-Cog)&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Item &quot;One Cognitive Scale (Mini-Cog)&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Experts Who Considered That the Item &quot;Char Lson Comorbidity Index&quot; Should be Retained in the G-CODE</title>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>National Panel of Experts</title>
            <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Experts Who Considered That the Item &quot;Char Lson Comorbidity Index&quot; Should be Retained in the G-CODE</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>National Panel of Experts</title>
          <description>National panel of experts involved in the scoring of the items/tools to be included in the G-CODE.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="42"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pr S Mathoulin-Pélissier</name_or_title>
      <organization>Institut Bergonié</organization>
      <phone>33 5 56 33 33 33</phone>
      <email>s.mathoulin@bordeaux.unicancer.fr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

